Guaifenesin Liquid
FDA Label NDC 81033-102

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Kesin Pharma Corporation for the product Guaifenesin (NDC 81033-102). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding drug facts, purpose, uses, warnings, do not use, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Purpose

Expectorant

Uses

  • helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

Warnings

Directions

  • take every 4 hours, as needed, or directed by a doctor
  • do not take more than 6 doses in 24 hours
  • do not exceed recommended dose
  • AgeDose
    adults and children 12 years and over2 to 4 tespoonfuls every 4 hours
    children 6 years to under 12 years1 to 2 teaspoonfuls every 4 hours
    children 2 years to under 6 years1/2 to 1 teaspoonful every 4 hours
    under 2 yearsask a doctor

Inactive Ingredients

citric acid, grape flavor, methylparaben, monoammonium glycyrrhizinate, potassium citrate, propylene glycol, propylparaben, purified water, sorbitol, sucralose

Questions Or Comments?

1-833-537-4679

* Please review the disclaimer below.